Ignite Creation Date:
2024-07-17 @ 10:44 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06482788
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2024-05-22
Brief Title:
Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy Adebrelimab Combined With Chemotherapy XELOX a Prospective Single-center Feasibility Study
Sponsor:
Ruijin Hospital
Organization:
Ruijin Hospital
Organization Data
Organization:
Ruijin Hospital
Class:
OTHER
Study ID:
RTS-023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ruijin Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None